주요 문서

모든 문서 보기

207713

1,3-Di-o-tolylguanidine

Name: 1,3-Di-<I>o</I>-tolylguanidine
Brand: ALDRICH

99%

동의어(들):

DTG

조직 및 계약 가격을 보려면 로그인를 클릭합니다.

크기 선택

보기 변경

제품정보 (DICE 배송 시 비용 별도)

Linear Formula:

(CH₃C₆H₄NH)₂C(=NH)

CAS 번호:

97-39-2

Molecular Weight:

239.32

NACRES:

NA.22

PubChem Substance ID:

24852467

UNSPSC Code:

12352100

EC Number:

202-577-6

MDL number:

MFCD00008513

Assay:

99%

Form:

solid

기술 서비스

도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.

도움 문의

속성

Quality Level

100

assay

99%

form

solid

mp

176-178 °C (lit.)

solubility

water: soluble 70 mg/mL at 20 °C

functional group

amine

SMILES string

Cc1ccccc1NC(=N)Nc2ccccc2C

InChI

1S/C15H17N3/c1-11-7-3-5-9-13(11)17-15(16)18-14-10-6-4-8-12(14)2/h3-10H,1-2H3,(H3,16,17,18)

InChI key

OPNUROKCUBTKLF-UHFFFAOYSA-N

Gene Information

human ... EBP(10682)

설명

General description

1,3-Di-o-tolylguanidine is a selective σ-receptor agonist. 1,3-Di-o-tolylguanidine is σ site ligand and its interaction with dopamine drugs were studied in Wistar rats and Albino Swiss mice.

pictograms

GHS07

signalword

Warning

hcodes

H302

Hazard Classifications

Acute Tox. 4 Oral

저장 등급

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

가장 최신 버전 중 하나를 선택하세요:

시험 성적서(COA)

Lot/Batch Number

적합한 버전을 찾을 수 없으신가요?

특정 버전이 필요한 경우 로트 번호나 배치 번호로 특정 인증서를 찾을 수 있습니다.

COA 검색

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

Sonication-assisted synthesis of a new cationic zinc nitrate complex with a tetradentate Schiff base ligand: Crystal structure, Hirshfeld surface analysis and investigation of different parameters influence on morphological properties.

S A Mousavi et al.

Ultrasonics sonochemistry, 46, 26-35 (2018-05-10)

A nanostructured cationic zinc nitrate complex with a formula of [ZnLNO3]NO3 (where L = (N2E,N2'E)-N1,N1'-(ethane-1,2-diyl)bis(N2-((E)-3-phenylallylidene)ethane-1,2-diamine)) was prepared by sonochemical process and characterized by single crystal X-ray crystallography, scanning electron microscopy (SEM), FT-IR and NMR spectroscopy and X-ray powder diffraction (XRPD). The X-ray

Novel secondary mutations C56S and G149A confer resistance to HIV-1 integrase strand transfer inhibitors.

Tomokazu Yoshinaga et al.

Antiviral research, 152, 1-9 (2018-02-08)

Cabotegravir (CAB, S/GSK1265744) is an investigational second-generation integrase strand transfer inhibitor (INSTI) with a chemical structure similar to dolutegravir. CAB is under development as a long-acting injectable formulation for treatment of HIV-1 infection and for pre-exposure prophylaxis. We conducted an

Ultra-long-acting removable drug delivery system for HIV treatment and prevention.

Martina Kovarova et al.

Nature communications, 9(1), 4156-4156 (2018-10-10)

Non-adherence to medication is an important health care problem, especially in the treatment of chronic conditions. Injectable long-acting (LA) formulations of antiretrovirals (ARVs) represent a viable alternative to improve adherence to HIV/AIDS treatment and prevention. However, the LA-ARV formulations currently

모든 관련된 서류 보기